The potential for interaction between warfarin and coprescribed medication: A retrospective study in primary care

American Journal of Cardiovascular Drugs

Volumn 8, Issue 3, 2008, Pages 207-212

  Snaith, Ailsa ^a   Pugh, Lyn ^a   Simpson, Colin R ^a   McLay, James S ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Antibacterials, drug interactions; Antithrombotics, drug interactions; Fibrinolytic agents, drug interactions; Macrolides, drug interactions; Nonsteroidal anti inflammatories, drug interactions; Warfarin, drug interactions

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; MACROLIDE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONAMIDE; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DATA BASE; DRUG ANTAGONISM; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; DRUG INTERACTIONS; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SCOTLAND; WARFARIN;

EID: 44949233631     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200808030-00007     Document Type: Article

References (23)

1. Jankel CA. Speedie SM. Detecting drug interactions: a review of the literature. DICP 1990; 24: 982-9
2. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-9
3. UK Department of Health. National Service Framework for Older People, 2001 [online]. Available from URL: http://www.doh.gov.uk/nsf/olderpeople.htm. [Accessed 2007 Apr 2]
4. UK Department of Health. Medicines and older people implementing medicines-related aspects of the NSF for older people, 2001 [online]. Available from URL: http://www.doh.gov.uk/nsf/olderpeople.htm. [Accessed 2007 Apr 5]
5. Evans MJ, Henderson L, Goudie B, et al. Demand for warfarin anticoagulation monitoring in Tayside, Scotland. Health Bull (Edinb) 1997; 55: 88-93
6. Holm T, Lassen JF. How many patients are on oral anticoagulation therapy in Denmark? Methods to estimate the number. Ugeskrift Laeger 2003; 165: 1871-5
7. Van der Meer F, Rosendaal F, Vandenbroucke J, et al. Bleeding complications in oral anticoagulant therapy. Arch Intern Med 1993; 153: 1557-62
8. Cannegieter S, Rosendaal F, Wintzen A, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333: 11-7
9. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulation Therapy. Lancet 1996; 348: 423-8
10. UK National Patient Safety Agency. Risk assessment of anticoagulant therapy, January 2006 [online]. Available from URL: http://www.npsa.nhs.uk/site/ media/documents/1773_AnticoagulantReport.pfd [Accessed 2007 Apr 4]
11. Paneerselvan S, Baglin C, Lefort W, et al. Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin. Br J Haematol 1998; 103: 422-4
12. Battistella M, Mamdami MM, Juurlink DN, et al. Risk of upper gastrointestinal hemorrhage in warfarin users treated with non selective NSAIDs or COX-2 inhibitors. Arch Intern Med 2005; 165: 189-92
13. Milne RM, Taylor MW, Taylor RJ. Audit of populations in general practice: the creation of a national resource for the study of morbidity in Scottish general practice. J Epidemiol Community Health 1998; 52 Suppl. 1: 20S-4S
14. Whitelaw FG, Nevin SL, Milne RM, et al. Completeness and accuracy of morbidity and repeat prescribing records held on general practice computers in Scotland. Br J Gen Pract 1996; 46: 181-6
15. Thomson Micromedex. DRUGDEX® system [online]. Available from URL: http://www.micromedex.com/products/drugdex/ [Accessed 2007 Apr 5]
16. Thomson Micromedex. DRUG-REAX® system [online]. Available from URL: http://www.micromedex.com/products/drugreax/ [Accessed 2007 Apr 5]
17. Andreotti F, Testa L, Biondi-Zoccai GGL, et al. Aspirin plus warfarin compared to aspirin alone after an acute coronary syndromes: an updated and comprehensive meta-analysis of 25307 patients. Eur Heart J 2006; 27: 519-26
18. Landefeld CS, Beyth RJ. Anticoagulant related bleeding: clinical epidemiology, prediction and prevention. Am J Med 1993; 95: 315-28
19. Fitzmaurice DA, Blann AD, Lip GYH. ABC of antithrombotic therapy. BMJ 2002; 325: 828-31
20. Wittkowsky AK, Boccuzzi S, Wogen J, et al. Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 2004; 24 (12): 1668-74
21. Malone DC, Hutchins DS, Haupert H, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm 2005; 62: 1983-91
22. Knijff-Dutmer EA, Schut GA, van de Laar MA. Concomitant coumarin-NSAID therapy and risk for bleeding. Ann Pharmacother 2003; 37: 12-6
23. Seymour RM, Routledge PA. Important drug-drug interactions in the elderly. Drugs Aging 1998; 12: 485-94